Arkolith/Insider Trading/VERA/Form 4

Turner William D.

Chief Regulatory OfficerVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Dec 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$400K
Net Open-Market Flow
-$400K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2025Sell(S)10K$40.00$400K23K
Dec 3, 2025Option exercise(M)10K$15.53$155K33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 3, 2025Option exercise(M)10K—$0265K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-308074) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML